Nurix Therapeutics Inc

-0.25 (-0.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.25B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$13.65 Million
Adjusted EPS-$0.67
See more estimates
10-Day MA$28.85
50-Day MA$31.84
200-Day MA$32.38
See more pivots

Nurix Therapeutics Inc Stock, NASDAQ:NRIX

1700 Owens Street, Suite 205, San Francisco, California 94158
United States of America
Phone: +1.415.660.5320
Number of Employees: 135


Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rap?©, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.